UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report: (date of earliest event reported):
July 25, 2017
CHEMED CORPORATION
(Exact name of registrant as specified in its charter)
|
Delaware |
1-8351 |
31-0791746 |
|
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification Number) |
|
Suite 2600, 255 East 5th Street, Cincinnati, OH |
45202 |
|
(Address of principal executive offices) |
(Zip Code) |
Registrant’s telephone number, including area code:
(513) 762-6690
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):
⃞ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
⃞ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
⃞ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
⃞ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Page 1of 2
| Item 2.02 | Results of Operations and Financial Condition |
On July 25, 2017 Chemed Corporation issued a press release announcing its financial results for the quarter ended June 30, 2017. A copy of the release is furnished herewith as Exhibit 99.
| Item 9.01 | Financial Statements and Exhibits |
| d) | Exhibit | |
|
(99) Registrant’s press release dated July 25, 2017 |
||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
CHEMED CORPORATION |
|||||
|
Dated: |
July 25, 2017 |
By: |
/s/ Michael D. Witzeman |
||
|
Michael D. Witzeman |
|||||
|
Vice President and Controller |
|||||
Page 2 of 2